Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.Yin Li, Guangying Zhu, Bo Xu et al.|PubMed|2012Cited by 57
Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancerDan Yang, Anhui Shi, Jianing Cui et al.|Thoracic Cancer|2020Cited by 16
Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma MarkersXin Sui, Weihu Wang, Leilei Jiang et al.|Frontiers in Oncology|2021Cited by 13
Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLCYing Ma, Rong Yu|Aging|2024Cited by 3
Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinomaBatter Han, Subudao Bao, Haiyong Zhu et al.|Aging|2024Cited by 2